Call/WhatsAppText +1 (302) 613-4617

Biology

What Are Hormones?

Home / Academic Skills / What Are Hormones?
ENDOCRINOLOGY  ·  PHYSIOLOGY  ·  BIOMEDICAL SCIENCE

What Are Hormones?

A complete, mechanistically grounded account of the endocrine system — from hormone classification and receptor mechanisms through the hypothalamic-pituitary axis, thyroid, adrenal, and sex hormones, glucose homeostasis, feedback regulation, hormone disorders, reproductive endocrinology, and the connections between hormones, immunity, and stress. For students in biology, nursing, medicine, pharmacy, and biomedical science.

55–65 min read All academic levels 50+ hormones covered 10,000+ words

Custom University Papers Biology and Health Sciences Team

Specialists in endocrinology, physiology, and biomedical science writing — supporting students across biology, nursing, medicine, pharmacy, and health sciences at undergraduate and postgraduate levels. Our team includes subject experts with research backgrounds in endocrine physiology, metabolic disease, and reproductive medicine.

Hormones are chemical messengers: molecules secreted by specialized cells or glands, released into the circulatory system, and carried to target tissues where they bind specific receptor proteins and produce coordinated physiological changes. This description, though concise, understates the scope of what hormones actually do. They regulate growth from the prenatal period through adolescence. They orchestrate the daily rhythms of metabolism, energy use, and appetite. They control the production and maturation of eggs and sperm, coordinate pregnancy, and drive parturition and lactation. They calibrate the immune system’s responsiveness to infection and injury. They direct the body’s response to physical and psychological stress. And they tune mood, cognition, and behaviour in ways that are only beginning to be understood.

The endocrine system — the collection of glands, tissues, and cells that produce hormones — does not work in isolation from other physiological systems. The nervous system communicates with it continuously, translating sensory inputs and cognitive states into hormonal outputs. The immune system is both regulated by hormones and, in turn, produces signaling molecules that function like hormones in their own right. The gut, kidneys, liver, heart, and adipose tissue all secrete hormonal signals that were only characterized as hormones relatively recently. The traditional image of a few discrete glands producing a handful of classical hormones substantially underrepresents the actual extent of endocrine communication in the body.

This guide provides a comprehensive account of what hormones are, how they are classified, how they work at the molecular level, which glands produce them, what they regulate, and what happens when their regulation fails. It covers the core endocrine axes examined in biology, nursing, pharmacy, and medicine curricula — and goes beyond the curriculum to address the integrative complexity that makes endocrinology one of the most conceptually rich areas of biomedical science.

What Hormones Are — Chemical Communication at Distance

The term hormone derives from the Greek word horman, meaning to set in motion or to excite — a name that reflects how early physiologists understood these substances: as chemical signals that activate distant tissues. The first formally described hormone was secretin, identified by William Bayliss and Ernest Starling in 1902 when they demonstrated that a substance released from the duodenal mucosa into the bloodstream could stimulate pancreatic secretion even after all nervous connections to the pancreas were severed. This experiment established the principle of chemical coordination independent of neural signaling — and introduced the concept of a blood-borne chemical messenger, which Starling named a hormone in 1905.

Today, the formal definition of a hormone encompasses any molecule that is secreted by a specialized cell or gland, enters the circulation, and travels to a target cell or tissue where it binds a specific receptor protein and triggers a biological response. This definition captures the three essential features of classical hormonal communication: secretion, transport, and receptor-mediated target action. It is these three features — and the specificity that receptor binding confers — that make hormonal signaling precise and coordinated across the entire body rather than random biochemical noise.

50+distinct hormones identified in the human body, produced by glands and tissues across every major organ system
<1 nMtypical circulating hormone concentration — hormones are biologically active at extraordinarily low concentrations due to high receptor affinity
msec–daysthe range of onset times for hormone effects — from milliseconds (catecholamines) to hours or days (steroid and thyroid hormones via gene transcription)
1902year secretin was described by Bayliss and Starling — the first formally characterized hormone, establishing the endocrine concept

The distinction between endocrine, paracrine, and autocrine signaling maps to the distance a chemical messenger travels from its source to its target. Classical endocrine hormones — insulin, cortisol, thyroxine — travel long distances through the bloodstream to reach distant target tissues. Paracrine messengers act locally on adjacent cells; the prostaglandins produced at a site of inflammation act on nearby blood vessels and immune cells without systemic distribution. Autocrine signals feed back onto the same cell that secreted them — a mechanism important in immune cell activation and tumour biology. Many molecules that we classify as hormones act in more than one of these modes depending on the context: testosterone acts as a classical endocrine hormone when secreted by the testes into the circulation to act on muscle and bone, but also acts in a paracrine mode within the testis itself to support spermatogenesis.

Endocrine

Hormone secreted into blood and carried to distant target tissues — classical long-range hormonal communication

Paracrine

Signaling molecule acts on adjacent cells locally without entering systemic circulation — e.g. prostaglandins, growth factors

Autocrine

Cell secretes a molecule that acts back on its own receptors — important in immune activation and tumour signaling

Neuroendocrine

Neurons secrete hormones directly into the bloodstream — hypothalamic releasing hormones are the primary example

Hormone Classification — Three Chemical Classes, Three Distinct Mechanisms

Hormone classification by chemical structure is not merely taxonomic. The chemical class of a hormone determines how it is synthesized, how it is stored and released, how it travels through the blood, which type of receptor it engages, and what time course of action it produces. Understanding chemical class is therefore the foundation for understanding mechanism — and for predicting how a given hormone will behave in pharmacological, pathological, and clinical contexts.

Chemical Class 1

Peptide and Protein Hormones

The largest and most diverse class — chains of amino acids ranging from three amino acids (thyrotropin-releasing hormone, TRH) to large glycoproteins of several hundred amino acids (thyroid-stimulating hormone, TSH; follicle-stimulating hormone, FSH; luteinizing hormone, LH). Peptide hormones are water-soluble and cannot cross the lipid bilayer of cell membranes. They therefore act on cell-surface receptors — G protein-coupled receptors, receptor tyrosine kinases, or cytokine receptors — and produce their effects through intracellular second-messenger cascades (cAMP, IP3/DAG, calcium, MAPK phosphorylation). Effects are typically rapid in onset (seconds to minutes for signaling cascade activation) because they do not require new gene transcription. Peptide hormones are synthesized as larger precursor proteins (preprohormones) in the endoplasmic reticulum, processed through the Golgi apparatus, and stored in secretory granules ready for rapid release on demand. Examples: insulin, glucagon, growth hormone, PTH, ACTH, ADH, oxytocin, GLP-1, leptin, GnRH, CRH.

Chemical Class 2

Steroid Hormones

Derived from cholesterol through a series of enzymatic modifications occurring primarily in the adrenal cortex and gonads (for classical steroid hormones) and skin, liver, and kidney (for vitamin D, which functions as a steroid hormone despite its synthesis route). Steroid hormones are lipophilic — they diffuse freely across cell membranes and do not require membrane receptors to enter cells. They act via intracellular nuclear receptors that function as ligand-activated transcription factors: hormone binds receptor, the complex translocates to the nucleus (or is already there), binds hormone-response elements on DNA, and regulates the transcription of target genes. Effects are therefore slow in onset (hours) and long in duration, reflecting the time required for gene transcription and protein synthesis. Steroid hormones travel in blood bound to carrier proteins (corticosteroid-binding globulin for cortisol, sex hormone-binding globulin for sex steroids) — only the unbound free fraction is biologically active. Examples: cortisol, aldosterone, oestradiol, testosterone, progesterone, DHEA, vitamin D (calcitriol).

Chemical Class 3

Amine Hormones

Derived from the amino acid tyrosine through a series of enzymatic modifications. The two sub-groups behave in fundamentally different ways despite their shared biosynthetic origin. Catecholamines (adrenaline/epinephrine, noradrenaline/norepinephrine, dopamine) — produced in the adrenal medulla and sympathetic nerve terminals — are water-soluble and act on cell-surface G protein-coupled adrenoceptors. Their effects are rapid (seconds) and short-lived, suited to the acute stress response. Thyroid hormones (T3 — triiodothyronine, and T4 — thyroxine) are lipophilic despite being amino acid derivatives, enter cells via specific membrane transporters, and act via nuclear thyroid hormone receptors (TRs) to regulate gene transcription — behaving mechanistically like steroid hormones. Their effects develop over days and persist for days to weeks, consistent with their role in setting the baseline metabolic rate.

Receptor Types

Matching Hormone Class to Receptor Location

The location of a hormone’s receptor is determined by its chemical class. Peptide and catecholamine hormones (water-soluble) cannot enter cells — their receptors are on the cell surface. Steroid and thyroid hormones (lipophilic) can enter cells — their receptors are intracellular. This determines where the signal is processed: cell-surface receptor engagement triggers cytoplasmic second-messenger cascades; nuclear receptor engagement directly modifies gene transcription. The clinical consequence is that steroid and thyroid hormone effects are slow to develop and slow to reverse — important for therapeutic management of conditions like hypothyroidism, where weeks of levothyroxine treatment are required before full physiological normalization occurs.

How Hormones Work — Receptor Binding and Signal Transduction

A hormone’s effect in a target tissue is entirely determined by the receptor proteins expressed in that tissue. The same hormone — adrenaline, for example — produces completely different effects in different tissues depending on which adrenoceptor subtype is present: beta-1 adrenoceptor activation in the heart increases heart rate and contractility; beta-2 adrenoceptor activation in bronchial smooth muscle produces bronchodilation; alpha-1 adrenoceptor activation in peripheral vascular smooth muscle produces vasoconstriction. This receptor-determined specificity means that the diversity of hormonal effects across tissues does not require a different hormone for each tissue — it requires different receptor subtypes with different downstream signaling profiles in each tissue.

G Protein-Coupled Receptor (GPCR) Signaling

The most common receptor mechanism for peptide hormones and catecholamines. Hormone binds the extracellular domain of the GPCR → receptor changes conformation → activates associated G protein (Gs, Gi, or Gq depending on receptor subtype) → G protein activates or inhibits an effector enzyme. Gs activates adenylyl cyclase → generates cyclic AMP (cAMP) → activates protein kinase A (PKA) → PKA phosphorylates target proteins including enzymes, ion channels, and transcription factors. Gi inhibits adenylyl cyclase, reducing cAMP. Gq activates phospholipase C → generates IP3 (releases intracellular Ca2+) and DAG (activates PKC). Each pathway produces distinct patterns of downstream phosphorylation that constitute the hormonal effect. Receptor desensitization through phosphorylation and internalization limits the duration of GPCR-mediated signaling — an important regulatory mechanism preventing chronic overstimulation.

Nuclear Receptor Signaling

The mechanism for steroid and thyroid hormones. The hormone diffuses across the cell membrane → binds its intracellular receptor (either in the cytoplasm or already in the nucleus depending on the receptor class) → the hormone-receptor complex undergoes conformational change → dimerizes and binds specific DNA sequences called hormone response elements (HREs) in the promoter regions of target genes → recruits coactivator or corepressor complexes → changes the rate of transcription of target genes → altered mRNA levels → altered protein expression. This pathway is intrinsically slow (hours) because it requires transcription and translation, but produces sustained effects because newly synthesized proteins persist after the hormone is cleared. Glucocorticoids regulate hundreds of genes through this mechanism — anti-inflammatory genes are upregulated; pro-inflammatory genes are downregulated — explaining both the power and the systemic effects of corticosteroid therapy.

Second-messenger cascades — summary of major GPCR signaling pathways Signal Transduction
Gs PATHWAY (stimulatory):
  Hormone → GPCR(Gs) → Adenylyl cyclase ↑ → cAMP ↑ → PKA activation
  Examples: TSH, ACTH, glucagon, adrenaline (beta-2), PTH, FSH, LH
  Effects: glycogenolysis, lipolysis, hormone biosynthesis, smooth muscle relaxation

Gi PATHWAY (inhibitory):
  Hormone → GPCR(Gi) → Adenylyl cyclase ↓ → cAMP ↓ → reduced PKA
  Examples: somatostatin, opioids, alpha-2 adrenoceptor agonists
  Effects: inhibition of secretion, reduced cell activity

Gq PATHWAY (phospholipase C):
  Hormone → GPCR(Gq) → PLC activation → IP3 + DAG
  IP3 → ER Ca²⁺ release → calmodulin activation → smooth muscle contraction
  DAG  → PKC activation → diverse phosphorylation targets
  Examples: GnRH, TRH, angiotensin II, oxytocin, alpha-1 adrenoceptors

RECEPTOR TYROSINE KINASE (RTK):
  Insulin → insulin receptor → autophosphorylation → IRS-1 → PI3K → Akt/PKB
  → GLUT4 translocation, glycogen synthesis, protein synthesis, cell survival

NUCLEAR RECEPTOR:
  Steroid/T3 → diffuses into cell → binds receptor → HRE binding → gene transcription ↑/↓
  Onset: hours. Duration: long (new protein persists after hormone clearance)

Hormone receptor number and sensitivity are themselves regulated — a phenomenon called up-regulation or down-regulation — as an additional layer of control beyond circulating hormone concentration. Prolonged exposure to high concentrations of a hormone typically causes receptor down-regulation: the cell reduces the number of surface receptors (through internalization and degradation) or reduces receptor sensitivity, attenuating the response to continued hormonal stimulation. This mechanism underlies the reduced tissue responsiveness that develops with chronic hormonal excess — including the reduced growth hormone responsiveness seen in acromegaly and, importantly, insulin resistance in type 2 diabetes, where chronic hyperinsulinaemia contributes to down-regulation of insulin receptor signaling. Conversely, prolonged hormone deficiency can produce receptor up-regulation — increased receptor expression that sensitizes the target tissue to lower hormone concentrations.

The Major Endocrine Glands and What They Produce

The endocrine system is distributed across the body — there is no single endocrine organ, just as there is no single immune organ. Specialized glands are the primary hormone-producing structures, but significant hormonal secretion also occurs from the gut, heart, kidneys, liver, adipose tissue, and the placenta during pregnancy. Understanding which structures produce which hormones, and the regulatory inputs governing their secretion, is the anatomical and physiological foundation of endocrinology.

Hypothalamus

The Neuroendocrine Controller

Produces releasing and inhibiting hormones that control pituitary secretion: CRH (corticotropin-releasing hormone), TRH (thyrotropin-releasing hormone), GnRH (gonadotropin-releasing hormone), GHRH (growth hormone-releasing hormone), somatostatin (GH inhibiting), dopamine (prolactin inhibiting). Also produces ADH (antidiuretic hormone/vasopressin) and oxytocin, which are transported to the posterior pituitary for storage and release. The hypothalamus integrates inputs from the limbic system, brainstem, and circulating hormones to translate physiological state into hormonal output — the critical link between the nervous system and the endocrine system.

Pituitary Gland

The Master Gland

Two functionally distinct lobes. Anterior pituitary (adenohypophysis) secretes: TSH (thyroid-stimulating hormone), ACTH (adrenocorticotropic hormone), FSH (follicle-stimulating hormone), LH (luteinizing hormone), GH (growth hormone), prolactin. Each is controlled by the corresponding hypothalamic releasing or inhibiting hormone. Posterior pituitary (neurohypophysis) releases ADH (regulates water reabsorption in the kidney — key for plasma osmolality and blood pressure) and oxytocin (uterine contraction during labour; milk ejection during breastfeeding; social bonding) — both synthesized in the hypothalamus and released from posterior pituitary axon terminals.

Thyroid Gland

Metabolic Rate Regulator

Produces T3 (triiodothyronine) and T4 (thyroxine) — synthesized from tyrosine and iodine in thyroid follicles, stored as thyroglobulin, and released under TSH stimulation. T4 is the primary secretory product but is largely inactive; it is converted to the more potent T3 by deiodinase enzymes in peripheral tissues (particularly liver and kidney). Both act via nuclear thyroid hormone receptors to regulate basal metabolic rate, thermogenesis, cardiac function, lipid metabolism, and growth. The thyroid also produces calcitonin from C cells — a peptide hormone lowering blood calcium by inhibiting osteoclast activity, though its physiological role in humans is minor compared to PTH.

Adrenal Glands

Stress and Salt Homeostasis

Two anatomically distinct structures in one gland. Adrenal cortex produces cortisol (zona fasciculata — under ACTH control), aldosterone (zona glomerulosa — under angiotensin II and potassium control), and adrenal androgens DHEA and androstenedione (zona reticularis). Adrenal medulla produces adrenaline (~80%) and noradrenaline (~20%) from chromaffin cells under sympathetic nervous system control — the acute catecholamine surge of the fight-or-flight response. Together, the adrenal glands coordinate both the rapid (catecholamine-mediated) and sustained (cortisol-mediated) responses to physiological stress.

Pancreas

Blood Glucose Homeostasis

The endocrine pancreas consists of the islets of Langerhans embedded within the exocrine pancreatic tissue. Beta cells (most abundant) produce insulin — the primary anabolic, glucose-lowering hormone. Alpha cells produce glucagon — the primary catabolic, glucose-raising counterregulatory hormone. Delta cells produce somatostatin — locally inhibiting both insulin and glucagon secretion. PP cells produce pancreatic polypeptide — involved in appetite regulation. The beta and alpha cells work in coordinated opposition: rising glucose stimulates insulin and suppresses glucagon; falling glucose suppresses insulin and stimulates glucagon — the foundation of blood glucose homeostasis.

Gonads

Sex Hormone Production

Testes: Leydig cells produce testosterone (primary male androgen) under LH stimulation; Sertoli cells produce inhibin B (suppresses FSH) and AMH (anti-Müllerian hormone, involved in male sex differentiation). Ovaries: theca cells produce androgens (androstenedione, testosterone) under LH stimulation; granulosa cells aromatize androgens to oestradiol under FSH stimulation; the corpus luteum produces progesterone after ovulation. Both gonads produce inhibin — a selective FSH inhibitor — providing the negative feedback signal that limits FSH secretion in proportion to gonadal function.

Non-Classical Endocrine Organs — Hormones Beyond the Traditional Glands

Many non-glandular organs produce hormones that were recognized only in the past few decades. Adipose tissue secretes leptin (satiety signal proportional to fat mass), adiponectin (insulin-sensitizing), and resistin (associated with insulin resistance). The heart secretes atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in response to atrial stretch — promoting natriuresis and vasodilation to reduce cardiovascular load. The kidneys produce erythropoietin (EPO — stimulating red blood cell production) and renin (initiating the renin-angiotensin-aldosterone system). The gut produces a diverse range of hormones: GLP-1 and GIP (incretins stimulating insulin secretion), ghrelin (appetite stimulator produced in the stomach), cholecystokinin (CCK — stimulating bile and pancreatic enzyme release, promoting satiety), and many others. Bone secretes osteocalcin — increasingly recognized as having endocrine functions regulating insulin secretion, male fertility, and cognition. The concept of distinct, discrete endocrine glands as the sole sites of hormone production is a considerable simplification of the actual distributed endocrine architecture of the human body.

The Hypothalamic-Pituitary Axis — The Brain’s Control of Body Physiology

The hypothalamic-pituitary axis is the regulatory architecture through which the brain directs the endocrine system. The hypothalamus sits at the base of the brain, ideally positioned to receive neural inputs from the limbic system (conveying emotional and psychological state), the brainstem (conveying cardiovascular and respiratory status), and the circumventricular organs (sensing blood-borne signals including glucose, osmolality, and circulating hormone concentrations). It integrates all these inputs and translates them into hormonal outputs that regulate pituitary function — and through the pituitary, the peripheral endocrine glands.

HPA Axis — Stress Response

CRH (hypothalamus) → ACTH (anterior pituitary) → Cortisol (adrenal cortex). Activated by physiological and psychological stress. Cortisol feeds back negatively to suppress both CRH and ACTH. Chronic CRH/ACTH excess produces Cushing’s disease; primary adrenal insufficiency (Addison’s disease) removes cortisol feedback, causing elevated ACTH with characteristic hyperpigmentation.

HPT Axis — Metabolic Rate

TRH (hypothalamus) → TSH (anterior pituitary) → T3/T4 (thyroid). Regulated by temperature, metabolic demand, and feedback from T3. T3 and T4 suppress both TRH and TSH. TSH measurement is the cornerstone of thyroid function assessment — it amplifies small changes in free T4 into large measurable TSH changes because of the log-linear nature of the feedback relationship.

HPG Axis — Reproduction

GnRH (hypothalamus, pulsatile) → FSH and LH (anterior pituitary) → Sex hormones + inhibin (gonads). GnRH must be released in pulses — continuous GnRH paradoxically suppresses FSH and LH, exploited therapeutically by GnRH agonist analogues in prostate cancer and endometriosis. Oestradiol feedback switches between negative (most of cycle) and positive (LH surge triggering ovulation) depending on concentration and duration.

The precision of hypothalamic-pituitary regulation depends on negative feedback operating at multiple levels simultaneously. In the HPT axis, circulating T3 and T4 suppress both hypothalamic TRH secretion and pituitary TSH secretion — with T3 (the more active form) exerting the dominant feedback effect. Because the feedback relationship between TSH and free T4 is log-linear, small changes in free T4 produce proportionally large changes in TSH — making TSH measurement the most sensitive indicator of thyroid hormone status and the cornerstone of thyroid function testing in clinical practice. A TSH slightly above the normal range indicates that free T4 is slightly below optimal even if it is still within the normal population reference range — the pituitary is sensing a mild deficiency and trying to compensate by increasing TSH drive.

Why TSH is Measured Rather Than T3/T4 for Initial Thyroid Screening

The pituitary’s high sensitivity to small changes in thyroid hormone concentrations makes TSH a more reliable screening test than measuring peripheral thyroid hormones directly. Because TSH responds exponentially to linear changes in free T4, it amplifies what might be a barely detectable fall in free T4 into a clearly abnormal TSH elevation. A patient with free T4 at the lower end of the normal range may have a TSH that is several-fold elevated — signaling subclinical hypothyroidism that free T4 measurement alone would miss.

Conversely, in hyperthyroidism, TSH is suppressed to near zero before free T4 and T3 are unambiguously elevated above the normal range — again, the TSH is the earlier and more sensitive indicator. The exception is secondary or tertiary hypothyroidism (pituitary or hypothalamic disease impairing TSH secretion), where TSH will be inappropriately low or normal despite low free thyroid hormones — making measurement of free T4 alongside TSH essential when pituitary pathology is suspected. For students writing endocrinology case studies or physiology assignments, our biology assignment help service provides subject-specialist support for exactly this type of integrated clinical-physiological reasoning.

Thyroid Hormones — Setting the Metabolic Rate

Thyroid hormones are the primary determinants of basal metabolic rate in virtually every tissue in the body. They regulate the rate at which cells consume oxygen and generate heat; they control protein synthesis, lipid metabolism, and carbohydrate utilization; they are essential for normal cardiac function, gut motility, nervous system development in the fetus and infant, and bone turnover in adults. The thyroid gland produces these effects through a single primary mechanism — nuclear receptor-mediated gene transcription — but the diversity of effects reflects the fact that thyroid hormone receptors are expressed in almost every tissue and regulate hundreds of target genes with diverse functions.

Hypothyroidism — Insufficient Thyroid Hormone
Hyperthyroidism — Excess Thyroid Hormone
Most Common CauseHashimoto’s thyroiditis (autoimmune destruction of thyroid follicles by anti-TPO and anti-thyroglobulin antibodies); iodine deficiency globally; post-radioiodine or surgical treatment of prior hyperthyroidism
Most Common CauseGraves’ disease (TSH receptor-stimulating IgG autoantibodies that chronically activate the TSH receptor, driving thyroid hormone overproduction independent of TSH); toxic multinodular goitre; thyroiditis (transient hyperthyroidism from follicular destruction)
Metabolic FeaturesWeight gain despite reduced appetite; cold intolerance; fatigue and lethargy; constipation; hyperlipidaemia (elevated LDL from reduced LDL receptor expression); reduced basal metabolic rate; bradycardia
Metabolic FeaturesWeight loss despite increased appetite; heat intolerance; sweating; hyperdefaecation; elevated HDL and reduced LDL; increased basal metabolic rate; tachycardia; atrial fibrillation risk
Neuromuscular FeaturesDepression; cognitive slowing; myopathy; delayed reflexes; carpal tunnel syndrome (myxoedema — accumulation of hydrophilic glycosaminoglycans in tissues); dry skin and hair; periorbital oedema
Neuromuscular FeaturesAnxiety; tremor; hyperreflexia; proximal myopathy; fine hair; Graves’ ophthalmopathy — exophthalmos and periorbital oedema from orbital glycosaminoglycan accumulation (an extrathyroidal autoimmune manifestation)
Biochemical PatternTSH elevated (primary hypothyroidism) — the pituitary is maximally stimulating a failing thyroid. Free T4 is low. Free T3 may be relatively preserved until late-stage disease. Anti-TPO antibodies positive in Hashimoto’s disease
Biochemical PatternTSH suppressed (primary hyperthyroidism) — the high thyroid hormones suppress pituitary TSH secretion. Free T4 and free T3 elevated. TSH receptor antibodies (TRAb) positive in Graves’ disease
TreatmentLevothyroxine (synthetic T4) oral daily replacement — dosed to normalize TSH. Lifelong treatment in autoimmune hypothyroidism. Dose adjusted for pregnancy, as requirements increase substantially in the first trimester
TreatmentAntithyroid drugs (carbimazole/methimazole, propylthiouracil) — block thyroid hormone synthesis. Radioiodine ablation — selectively destroys thyroid tissue. Thyroidectomy. Beta-blockers for symptomatic tachycardia and tremor

Adrenal Hormones — Cortisol, Adrenaline, and Aldosterone

The adrenal glands produce three functionally distinct hormone classes from two anatomically distinct regions — and each class addresses a different aspect of physiological challenge. Cortisol coordinates the sustained metabolic response to stress. Adrenaline mediates the rapid cardiovascular and metabolic response to acute threat. Aldosterone regulates long-term sodium and fluid balance to maintain blood pressure. Together they represent the primary hormonal armamentarium for maintaining physiological stability in the face of external challenge — a function whose importance is underscored by the life-threatening consequences of adrenal insufficiency, where the body loses the capacity to mount any of these responses adequately.

Cortisol — The Glucocorticoid That Runs the Stress Response

Cortisol is synthesized in the zona fasciculata of the adrenal cortex from cholesterol, under the continuous regulation of ACTH from the anterior pituitary. Its secretion follows a pronounced circadian rhythm: highest in the early morning hours (peaking around 8–9am), lowest in the late evening and early sleep. This rhythm is driven by circadian ACTH pulses and anticipates the metabolic demands of waking activity. Superimposed on this baseline rhythm are acute stress-induced spikes in ACTH and cortisol — the HPA stress response — triggered by physical injury, illness, hypoglycaemia, pain, and psychological stress.

Cortisol’s metabolic effects are broadly catabolic and glucose-conserving: it stimulates hepatic gluconeogenesis (raising blood glucose), promotes skeletal muscle protein breakdown to supply gluconeogenic amino acids, stimulates lipolysis to provide fatty acid fuel, and reduces peripheral glucose uptake in non-essential tissues. This metabolic profile makes sense in the context of acute stress — it prioritizes glucose delivery to the brain and active muscles when survival demands it. Cortisol’s anti-inflammatory effects — suppressing cytokine production, reducing immune cell trafficking, stabilizing lysosomal and cell membranes — are the basis for pharmacological corticosteroid therapy in inflammatory and autoimmune conditions, but also for the immunosuppressive adverse effects of chronic high-dose steroid treatment.

Aldosterone, produced in the zona glomerulosa under the primary control of angiotensin II and plasma potassium, acts on the principal cells of the renal collecting duct to increase expression of sodium channels (ENaC) and Na/K-ATPase pumps — promoting sodium reabsorption and potassium excretion. Water follows sodium osmotically, expanding extracellular fluid volume and raising blood pressure. Aldosterone is the primary mineralocorticoid effector of the renin-angiotensin-aldosterone system (RAAS), which operates as the long-term blood pressure regulator. Excess aldosterone (Conn’s syndrome — primary hyperaldosteronism, most commonly from an adrenal adenoma) produces hypertension and hypokalaemia; aldosterone deficiency (Addison’s disease — adrenal insufficiency) produces hypotension, hyponatraemia, and dangerous hyperkalaemia.

Adrenal Hormone Summary

  • Cortisol — glucocorticoid, stress, anti-inflammatory
  • Aldosterone — mineralocorticoid, Na/K balance, BP
  • DHEA / androstenedione — adrenal androgens
  • Adrenaline (~80%) — fight-or-flight, beta and alpha effects
  • Noradrenaline (~20%) — primarily alpha-adrenergic
  • Cortisol peaks 8–9am (circadian rhythm)
  • Aldosterone controlled by angiotensin II and K+
  • Catecholamines released within seconds of threat
  • Cortisol effect sustained over hours to days

Adrenaline (epinephrine) produces its effects within seconds of adrenal medullary release because it acts on cell-surface GPCRs rather than nuclear receptors. Its cardiovascular effects — increased heart rate, increased cardiac contractility, vasodilation in skeletal muscle (beta-2), vasoconstriction in skin and gut (alpha-1) — redirect blood flow toward the muscles and brain during acute stress. Its metabolic effects — glycogenolysis in liver and muscle (raising blood glucose), lipolysis in adipose tissue — mobilize fuel rapidly. Bronchodilation (beta-2 in airway smooth muscle) increases respiratory capacity. Together, these responses constitute the acute physiological fight-or-flight reaction. Pharmacological exploitation of this system includes: adrenaline injection for anaphylaxis (reverses bronchospasm and hypotension); beta-blockers (competitive antagonists at beta-adrenoceptors) for hypertension, angina, and heart failure; and beta-2 agonist inhalers (salbutamol/albuterol) for asthma — direct applications of adrenal pharmacology to clinical medicine.

Insulin, Glucagon, and the Hormonal Regulation of Blood Glucose

Blood glucose homeostasis is maintained within a narrow physiological range — approximately 3.9–5.6 mmol/L (70–100 mg/dL) in the fasting state — through the precisely coordinated opposing actions of insulin and glucagon. This regulatory precision matters because both extremes of glucose concentration are dangerous: hyperglycaemia causes oxidative damage to vascular endothelium and peripheral neurons (the basis of diabetic complications); hypoglycaemia deprives the brain of its primary fuel and can cause loss of consciousness and permanent neurological damage within minutes.

Post-Meal State — Insulin Dominance

Rising blood glucose after a meal stimulates pancreatic beta cells to secrete insulin via a direct glucose-sensing mechanism: glucose enters beta cells through GLUT2 transporters, is metabolized to ATP, which closes ATP-sensitive K+ channels, depolarizing the cell membrane and triggering calcium influx through voltage-gated calcium channels, which triggers exocytosis of insulin-containing secretory granules. Insulin acts on skeletal muscle (the primary site of glucose disposal — promoting GLUT4 translocation and glycogen synthesis), adipose tissue (promoting triglyceride storage and inhibiting lipolysis), and liver (promoting glycogen synthesis and inhibiting glucose output). The incretin hormones GLP-1 and GIP, released from intestinal L and K cells in response to nutrient presence, amplify the insulin secretory response to oral glucose — explaining why oral glucose produces a greater insulin response than intravenous glucose at the same concentration (the incretin effect). GLP-1 receptor agonists (liraglutide, semaglutide) and DPP-4 inhibitors (which prevent GLP-1 degradation) are widely used antidiabetic drugs that exploit this incretin axis.

Fasting State — Glucagon Dominance

As blood glucose falls during fasting, insulin secretion declines and pancreatic alpha cells increase glucagon secretion. Glucagon acts primarily on the liver, binding glucagon receptors coupled to the Gs-cAMP-PKA pathway, activating glycogenolysis (releasing glucose from hepatic glycogen stores) and gluconeogenesis (synthesizing new glucose from amino acids, lactate, and glycerol). Together these mechanisms raise blood glucose back toward the normal fasting range. Simultaneously, glucagon stimulates lipolysis in adipose tissue — releasing fatty acids that serve as alternative fuel for tissues other than the brain, sparing glucose for neurons. The brain and red blood cells are absolutely glucose-dependent (lacking mitochondria or glucose-independence mechanisms), making their continuous glucose supply the central objective of counter-regulatory hormonal responses to hypoglycaemia.

Hypoglycaemia Counter-Regulation — The Full Hormonal Response

When blood glucose falls below approximately 3.6 mmol/L, a cascade of counter-regulatory responses is activated in sequence. Glucagon is the first and most important: it acts within minutes to stimulate hepatic glucose output. Adrenaline provides the second major defence — both raising blood glucose through hepatic glycogenolysis and adipose tissue lipolysis, and producing the autonomic symptoms of hypoglycaemia (sweating, tremor, tachycardia, anxiety) that warn the patient to eat. Growth hormone and cortisol are slower counter-regulatory hormones that reduce peripheral glucose utilization and promote gluconeogenesis over hours, preventing recurrent hypoglycaemia. In type 1 diabetes, the failure of glucagon counter-regulation (impaired in long-standing disease) and the loss of adrenaline warning symptoms (hypoglycaemia unawareness from autonomic neuropathy) remove the two primary defences against hypoglycaemia, substantially increasing hypoglycaemic risk from insulin therapy.

Insulin Resistance and Type 2 Diabetes — Defective Glucose Regulation

Insulin resistance — reduced responsiveness of target tissues (particularly skeletal muscle, liver, and adipose tissue) to insulin — is the primary metabolic defect in type 2 diabetes. At the cellular level, it involves impaired insulin receptor signaling: reduced IRS-1 phosphorylation, reduced PI3K and Akt activity, and consequently reduced GLUT4 translocation and glycogen synthesis in skeletal muscle. Initially compensated by beta cell hyperinsulinaemia — producing more insulin to overcome the resistance — type 2 diabetes becomes manifest when beta cell exhaustion and progressive dysfunction reduce insulin secretory capacity below the level required to maintain normal glucose. The resulting chronic hyperglycaemia damages blood vessels (retinopathy, nephropathy, cardiovascular disease) and nerves (peripheral neuropathy) — the complications that define diabetes as a progressive disease rather than simply an elevated laboratory value.

Sex Hormones — Oestrogens, Androgens, and Progesterone

The sex hormones — oestrogens, androgens, and progesterone — are steroid hormones produced primarily in the gonads under pituitary gonadotropin control, though the adrenal cortex and adipose tissue also contribute to the androgen and oestrogen pool. Their primary functions are reproductive — governing the development of primary and secondary sex characteristics, regulating the menstrual cycle, supporting pregnancy, and driving gametogenesis — but their effects extend broadly across physiology: they regulate bone density, cardiovascular function, lipid metabolism, mood, cognition, and immune responsiveness.

🔵

Oestrogens — Primary Female Sex Hormones

Three main forms: oestradiol (E2 — dominant in reproductive years, most potent), oestriol (E3 — predominant in pregnancy), oestrone (E1 — predominant after menopause, produced by aromatization in adipose tissue). Synthesized primarily in granulosa cells of ovarian follicles by aromatization of androgens under FSH stimulation. Act via oestrogen receptor alpha (ERα) and beta (ERβ) nuclear receptors. Functions: endometrial proliferation; maintaining secondary sex characteristics; regulating the HPG axis (both negative and positive feedback on FSH/LH); bone density maintenance (inhibiting osteoclast activity); cardiovascular protection in premenopausal women; cognition and mood effects; hepatic protein synthesis regulation (including coagulation factors, SHBG, binding globulins).

🟡

Androgens — Primary Male Sex Hormones

Testosterone is the primary circulating androgen — produced by testicular Leydig cells under LH stimulation. Converted in target tissues either to the more potent dihydrotestosterone (DHT — by 5α-reductase, important in prostate and skin) or to oestradiol (by aromatase, important in bone, brain, and cardiovascular tissues). Act via the androgen receptor (AR) nuclear receptor. Functions: virilization during fetal development and puberty; spermatogenesis support; muscle mass and strength; bone density; libido; erythropoiesis; secondary male characteristics. In females, androgens serve as oestrogen precursors and maintain libido, muscle mass, and well-being; excess androgen in females (as in polycystic ovary syndrome — PCOS) produces hirsutism, acne, and menstrual irregularity.

🟣

Progesterone — The Pregnancy Hormone

Produced by the corpus luteum after ovulation (under LH stimulation), and by the placenta in pregnancy. Acts via the progesterone receptor (PR) nuclear receptor. Functions: preparing the endometrium for implantation (secretory transformation); maintaining uterine quiescence during pregnancy (preventing premature contractions); promoting development of mammary gland alveoli for lactation; raising the thermoregulatory set point (responsible for the body temperature rise after ovulation, used in fertility monitoring); immunomodulatory effects that facilitate fetal tolerance. In the absence of fertilization, corpus luteum regression causes progesterone withdrawal — triggering menstruation and resetting the cycle.

Oestradiol is not simply a female hormone — it is essential in males too. Male bone density, libido, and cardiovascular health depend significantly on oestradiol converted locally from testosterone by aromatase in bone, brain, and vascular tissue. Men with aromatase deficiency develop progressive osteoporosis and unfused epiphyses despite normal testosterone levels — because it is oestradiol, not testosterone directly, that maintains bone density and mediates epiphyseal closure. — Principle derived from clinical observations in men with aromatase deficiency and estrogen receptor mutations, establishing estradiol’s essential roles in male physiology

Feedback Loops and Hormonal Homeostasis

Feedback regulation is the mechanism that prevents hormone concentrations from drifting indefinitely in either direction — it is the control system that maintains endocrine homeostasis. The predominant form of hormonal feedback is negative feedback: the product of a hormonal signal suppresses the upstream signals that generated it, creating a self-limiting loop that stabilizes hormone concentrations around a set point. Positive feedback is rarer — it exists in specific physiological contexts where a brief, rapidly escalating response is required rather than a stable equilibrium.

−FB

Negative Feedback — The Homeostatic Default

The HPT, HPA, and HPG axes all operate through negative feedback loops. High thyroid hormone suppresses TRH and TSH; high cortisol suppresses CRH and ACTH; high sex steroids suppress GnRH and FSH/LH. The system is self-correcting — perturbations in either direction trigger corrective hormonal responses that restore the set point.

+FB

Positive Feedback — The Exception

The LH surge at ovulation is the primary example of positive feedback: rising oestradiol (from a dominant follicle reaching threshold) switches from negative to positive feedback on the pituitary, triggering a massive LH surge that causes ovulation. Oxytocin during labour is another: uterine contractions stimulate oxytocin release, which strengthens contractions, increasing oxytocin further — a self-amplifying loop terminated by delivery.

Set Point

Set Points and Their Disruption

Each hormonal axis operates around a physiological set point — the target concentration the feedback system defends. Set points are not fixed: they shift with age, pregnancy, illness, and chronic disease. In obesity, the leptin set point appears to be reset upward — leptin resistance parallels insulin resistance, with the hypothalamus failing to respond to elevated leptin with appropriate satiety signaling.

HPT axis negative feedback — clinical diagnostic interpretation Endocrine Logic
CLINICAL SCENARIO: Patient presents with fatigue, weight gain, cold intolerance

EXPECTED FEEDBACK RELATIONSHIP:
  Normal:    Hypothalamus (TRH) → Pituitary (TSH) → Thyroid (T3/T4)
              T3/T4 high → suppresses TRH and TSH → reduced stimulation
              T3/T4 low  → releases TRH and TSH → increased stimulation

LABORATORY RESULT:
  TSH:    15.2 mU/L    [↑ elevated — normal: 0.4–4.0]
  Free T4:  8.1 pmol/L   [↓ low — normal: 12–22]

INTERPRETATION:
  Primary hypothyroidism — the thyroid gland is failing to produce adequate T4.
  Reduced T4 removes negative feedback on the pituitary → pituitary maximally
  stimulates the failing thyroid → elevated TSH reflects the pituitary's
  attempt to compensate for insufficient peripheral thyroid hormone.

CONTRASTING PATTERN — Hyperthyroidism:
  TSH:    <0.01 mU/L   [↓↓ suppressed]
  Free T4:  38.5 pmol/L  [↑↑ elevated]
  High T4 → strong negative feedback → TSH suppressed to near zero
  The TSH suppression is the most sensitive early indicator of hyperthyroidism.

Growth Hormone, IGF-1, and Somatic Growth

Growth hormone (GH) is a 191-amino acid peptide secreted by somatotroph cells of the anterior pituitary in pulsatile bursts — predominantly during slow-wave sleep and in response to exercise, fasting, hypoglycaemia, and stress. Its secretion is regulated by hypothalamic GHRH (stimulatory) and somatostatin (inhibitory), and by the feedback effects of IGF-1 and GH itself. Most of GH’s growth-promoting effects are mediated indirectly through insulin-like growth factor 1 (IGF-1), produced primarily in the liver in response to GH receptor activation.

Growth Hormone in Childhood — Linear Growth

During childhood and adolescence, GH stimulates hepatic IGF-1 production, which acts on growth plate chondrocytes to promote longitudinal bone growth — the cellular basis of linear height increase. IGF-1 acts via the IGF-1 receptor (a receptor tyrosine kinase structurally related to the insulin receptor) to promote chondrocyte proliferation, matrix synthesis, and eventual hypertrophic differentiation in the growth plate. GH also promotes protein synthesis (anabolic effect), lipolysis, and has anti-insulin actions on glucose metabolism. GH deficiency in childhood — from pituitary pathology, GHRH deficiency, or GH receptor mutations — produces short stature with proportionate body proportions. Recombinant human GH therapy is an established treatment for GH deficiency and several other growth-related conditions. Growth plates (epiphyseal plates) close under sex steroid influence at puberty, ending the capacity for linear growth — which is why delayed puberty can sometimes be advantageous for final height, and why early puberty curtails final stature despite accelerated childhood growth.

Growth Hormone in Adults — Metabolic Effects

Once the growth plates have closed, GH continues to be secreted and serves important metabolic roles. It maintains body composition by promoting lipolysis (reducing fat mass) and lean body mass preservation (protein-sparing, anabolic effects on muscle). It supports cardiac function, glucose metabolism, and bone density. Adult GH deficiency — from pituitary disease, pituitary surgery, or cranial irradiation — produces a characteristic syndrome of increased fat mass (particularly visceral adiposity), reduced lean body mass, reduced exercise capacity, reduced bone density, and impaired quality of life. GH excess in adults — from a GH-secreting pituitary adenoma — causes acromegaly: progressive enlargement of the hands, feet, and facial features due to periosteal bone overgrowth and soft tissue expansion under chronic IGF-1 stimulation. The Endocrine Society publishes clinical practice guidelines for GH deficiency and excess, available at endocrine.org.

Hormones in Reproduction and Pregnancy

Reproduction is the most hormonally complex physiological process — it requires the coordinated activity of the HPG axis, the ovary, the uterus, and ultimately the placenta across a sequence of tightly timed events. A failure at any hormonal step — inadequate GnRH pulsatility, impaired FSH signaling, deficient oestradiol production, absent LH surge, insufficient progesterone support — can interrupt fertility. Understanding the hormonal architecture of the menstrual cycle and early pregnancy is foundational for nursing, midwifery, medicine, and reproductive biology students.

1

Follicular Phase (Days 1–14) — FSH Drives Follicle Development

Menstruation marks day 1 of the cycle. Falling progesterone and oestradiol in the late luteal phase remove negative feedback, allowing FSH to rise and recruit a cohort of antral follicles. Dominant follicle selection — one follicle grows preferentially under FSH stimulation while the others undergo atresia — occurs around day 6–8. The dominant follicle’s granulosa cells increasingly produce oestradiol, which stimulates endometrial proliferation (building the uterine lining for potential implantation) and progressively suppresses FSH (negative feedback). As oestradiol concentration rises toward mid-cycle, it eventually reaches the threshold and duration for positive feedback on the pituitary — triggering the LH surge.

2

Ovulation — The LH Surge

The LH surge — a rapid, large increase in LH (and smaller FSH surge) driven by positive oestradiol feedback — occurs approximately 36–38 hours before ovulation. LH triggers final oocyte maturation (completion of the first meiotic division), prostaglandin-mediated follicle wall rupture, and release of the mature oocyte from the dominant follicle. The LH surge is the basis of urinary LH detection in home ovulation predictor kits — it is detectable in urine approximately 12–24 hours before ovulation, providing a practical window for timing of intercourse or insemination.

3

Luteal Phase (Days 14–28) — Corpus Luteum and Progesterone

After ovulation, the ruptured follicle transforms into the corpus luteum under continued LH stimulation. The corpus luteum secretes progesterone as its primary product (with some oestradiol), producing the secretory transformation of the endometrium — converting it from a proliferative to a secretory state suitable for blastocyst implantation. Progesterone also suppresses the HPG axis (preventing new follicle recruitment), raises basal body temperature, and thickens cervical mucus (reducing sperm penetration — the basis of progesterone-only contraception’s partial mechanism). If fertilization does not occur, the corpus luteum involutes after approximately 10–14 days, progesterone and oestradiol fall, and menstruation ensues — beginning the next cycle.

4

Early Pregnancy — hCG Rescues the Corpus Luteum

If fertilization and implantation occur, the trophoblast cells of the developing embryo begin producing human chorionic gonadotropin (hCG) — a glycoprotein hormone structurally similar to LH that binds the LH receptor and rescues the corpus luteum from its programmed involution. hCG maintains corpus luteum progesterone production through the first trimester, sustaining endometrial integrity and preventing menstruation. hCG is the hormone detected by pregnancy tests — urine hCG becomes detectable approximately 10–14 days after conception. Around 8–10 weeks gestation, the placenta takes over progesterone production (the luteal-placental shift) and the corpus luteum becomes redundant.

5

Pregnancy Hormones — Placental Endocrine Function

The placenta becomes a major endocrine organ from the end of the first trimester, producing: progesterone (maintaining uterine quiescence and preventing premature labour); oestrogens including oestriol (promoting uterine blood flow and breast development); human placental lactogen (hPL — acting like growth hormone and prolactin, promoting maternal nutrient mobilization including insulin resistance, directing glucose and amino acids toward the fetus); and CRH (driving the progressive activation of the fetal HPA axis toward parturition). The dramatic hormonal environment of pregnancy — characterized by progressive progesterone and oestrogen elevation, physiological insulin resistance (driven by hPL and cortisol), and substantially altered thyroid hormone kinetics — represents one of the most extensive hormonal reconfigurations the human body undergoes.

Hormones, Immunity, and the Stress Response

The endocrine and immune systems are not separate physiological compartments — they are deeply interconnected through bidirectional signaling. Hormones regulate immune function; immune mediators regulate hormone secretion. The concept of psychoneuroimmunology — the study of how psychological state, the nervous system, the endocrine system, and the immune system influence each other — captures this integration and explains why stress affects susceptibility to infection, why immune activation alters mood and behaviour, and why certain autoimmune conditions are modulated by reproductive hormones.

Cortisol and Immune Suppression

Cortisol has broad immunosuppressive and anti-inflammatory effects: it inhibits NF-κB (a master transcription factor for pro-inflammatory cytokines), reduces production of IL-1, IL-6, TNF-α, and IL-12, suppresses T cell activation and proliferation, inhibits neutrophil and macrophage function, and stabilizes mast cell degranulation. These effects make pharmacological glucocorticoids essential anti-inflammatory medicines, but also explain why chronic stress — and its associated cortisol elevation — impairs immune defences and increases susceptibility to infection and delayed wound healing.

Immune Cytokines as Hormone-Like Signals

During infection and inflammation, immune cells produce cytokines — particularly IL-1β, IL-6, and TNF-α — that have systemic hormone-like effects: inducing fever (via prostaglandin E2 in the hypothalamus), activating the HPA axis (IL-6 directly stimulates CRH and ACTH secretion), suppressing appetite (via hypothalamic action), and producing the malaise, fatigue, and social withdrawal of illness behaviour. These systemic effects are coordinated responses to infection that promote immune activation and energy conservation for immune function — they are adaptive, not merely pathological, though they become maladaptive when chronically elevated in inflammatory disease.

Sex Hormones and Immune Regulation

Sex hormone differences in immune function contribute to the well-documented female predominance of autoimmune disease (approximately 4:1 female-to-male ratio for many autoimmune conditions). Oestrogens generally enhance innate and adaptive immune responses — beneficial for infection resistance, but also amplifying autoreactive immune responses. Testosterone is broadly immunosuppressive — potentially explaining the lower autoimmune disease rate in males. The fluctuations in sex hormones during the menstrual cycle, pregnancy, and menopause are associated with characteristic fluctuations in autoimmune disease activity: lupus and rheumatoid arthritis often remit during pregnancy (driven by high progesterone and oestrogen immunomodulation) and flare post-partum when these hormones withdraw.

Hormone Disorders — When the Endocrine System Fails

Endocrine disorders arise from four primary mechanisms: insufficient hormone production (hyposecretion), excess hormone production (hypersecretion), impaired hormone receptor function (resistance), and impaired hormone transport or metabolism. Each mechanism produces a characteristic clinical pattern — and clinical endocrinology diagnoses these patterns by combining clinical assessment with biochemical testing that exploits knowledge of the feedback loops governing normal hormonal regulation. The NIDDK’s endocrine disease resource provides comprehensive information on the most common endocrine conditions seen in clinical practice.

Disorder Type 1

Primary Gland Failure (Hyposecretion)

Failure of the hormone-producing gland itself — autoimmune destruction (Hashimoto’s thyroiditis for the thyroid; Addison’s disease for the adrenal cortex; type 1 diabetes for the beta cells), surgical removal, radiation damage, infiltrative disease, or congenital absence. Pattern: low peripheral hormone, high trophic hormone (because negative feedback is removed). Examples: primary hypothyroidism (low T4, high TSH); primary adrenal insufficiency (low cortisol, high ACTH); primary hypogonadism (low testosterone/oestradiol, high FSH/LH). Treatment: replace the missing hormone — levothyroxine, hydrocortisone, testosterone, oestrogen.

Disorder Type 2

Autonomous Gland Overactivity (Hypersecretion)

Autonomous hormone production from a gland independent of normal trophic hormone control — typically from a benign adenoma. Pattern: high peripheral hormone, low or suppressed trophic hormone (because negative feedback is intact and the pituitary is trying to suppress the autonomous production). Examples: primary hyperaldosteronism (Conn’s syndrome — aldosterone-producing adrenal adenoma: high aldosterone, low renin); Graves’ disease (TSH receptor antibody-driven thyroid activation: high T3/T4, suppressed TSH); primary hyperparathyroidism (PTH-producing parathyroid adenoma: high PTH, high calcium). Treatment: remove or ablate the autonomous tissue (surgery, radioiodine, medical therapy reducing secretion).

Disorder Type 3

Pituitary or Hypothalamic Disease (Secondary/Tertiary)

Loss of trophic hormone drive to a normally functioning peripheral gland — from pituitary tumour, apoplexy, cranial irradiation, infiltrative disease, or hypothalamic pathology. Pattern: low peripheral hormone AND inappropriately low (or normal) trophic hormone. Examples: secondary hypothyroidism from pituitary insufficiency (low T4, low-normal TSH — contrasting with primary hypothyroidism where TSH is elevated); secondary hypogonadism (low testosterone, low-normal LH/FSH). Treatment: replace the peripheral hormone — because the normal gland will not respond without trophic drive, attempting to stimulate it (as with thyroid stimulating therapy) is not possible when the pituitary is damaged.

Disorder Type 4

Hormone Resistance Syndromes

Normal or elevated hormone production, but impaired target tissue response due to receptor mutation or signaling defect. Pattern: high or inappropriately elevated hormone with inadequate physiological response. Examples: type 2 diabetes (insulin resistance — elevated insulin with inadequate glucose-lowering); Laron syndrome (GH receptor mutation — normal/high GH, very low IGF-1, severe short stature); androgen insensitivity syndrome (AIS — normal or high testosterone, absent androgen receptor response — XY individuals with female external phenotype); thyroid hormone resistance (elevated T3/T4 with inappropriately unsuppressed TSH — reduced nuclear receptor sensitivity). Treatment: often addresses the downstream deficiency rather than the upstream excess — e.g., IGF-1 replacement in Laron syndrome.

Disorder Type 5

Cushing’s Syndrome — Glucocorticoid Excess

Excess cortisol — most commonly from exogenous glucocorticoid therapy (iatrogenic Cushing’s); from an ACTH-secreting pituitary adenoma (Cushing’s disease — bilateral adrenal hyperplasia from excess ACTH); from ectopic ACTH secretion (most commonly from small cell lung carcinoma); or rarely from a primary adrenal adenoma/carcinoma. Features: central obesity (truncal fat deposition, buffalo hump, moon face), thin skin and easy bruising, stretch marks (purple striae), proximal myopathy, hypertension, hyperglycaemia, osteoporosis, immunosuppression, and psychiatric effects. Diagnosis involves late-night salivary cortisol, 24-hour urinary free cortisol, and dexamethasone suppression testing.

Disorder Type 6

PCOS — Polycystic Ovary Syndrome

The most common endocrine disorder in women of reproductive age, affecting approximately 10% of this population. Characterized by oligo/anovulation (irregular or absent periods), biochemical or clinical hyperandrogenism (elevated testosterone, hirsutism, acne), and polycystic ovarian morphology on ultrasound — the Rotterdam criteria require two of these three. Underlying pathophysiology involves insulin resistance driving excess ovarian androgen production (LH-stimulated thecal cell hyperandrogenism), impaired follicle maturation, and chronic anovulation. The Endocrine Society classifies PCOS as both a reproductive and metabolic disorder — associated with insulin resistance, type 2 diabetes risk, dyslipidaemia, and cardiovascular risk beyond the reproductive manifestations.

Disorder Type 7

Diabetes Insipidus — ADH Deficiency

Deficient ADH (antidiuretic hormone/vasopressin) production or action — producing an inability to concentrate urine and consequent excretion of large volumes of dilute urine (polyuria — often 3–20 litres/day) and compensatory polydipsia. Cranial diabetes insipidus: ADH deficiency from hypothalamic or posterior pituitary pathology (tumour, surgery, trauma, autoimmune). Nephrogenic diabetes insipidus: normal ADH production but renal resistance to ADH action (from lithium toxicity, hereditary V2 receptor mutations, or electrolyte disturbance). Distinguished from primary polydipsia (excessive fluid intake driving dilute urine) by the water deprivation test. Treatment: desmopressin (synthetic ADH analogue) for cranial DI.

Disorder Type 8

Hypoparathyroidism and Hyperparathyroidism

Parathyroid hormone (PTH) regulates calcium and phosphate balance by acting on bone (stimulating osteoclastic resorption, releasing calcium), kidney (promoting calcium reabsorption, phosphate excretion, and activating vitamin D), and indirectly the gut (via activated vitamin D — calcitriol — increasing intestinal calcium absorption). Hypoparathyroidism (most commonly post-thyroid or parathyroid surgery, or autoimmune) causes hypocalcaemia: tetany, paraesthesias, prolonged QT, and seizures. Hyperparathyroidism (primary — usually from a parathyroid adenoma) causes hypercalcaemia: ‘bones, stones, groans, and psychic moans’ — bone resorption, nephrolithiasis, abdominal pain, and neuropsychiatric symptoms.

Biology, Nursing, and Health Sciences Academic Support

From endocrinology assignments and physiology essays to nursing case studies and biomedical research papers — subject specialists available across all health science disciplines at every academic level.

Expert Science and Healthcare Academic Writing Support

From hormones and endocrinology essays to physiology dissertations, nursing case studies, and biomedical research papers — specialists available at all levels across biology, pharmacy, medicine, and health sciences.

Biology Assignments Get Started

Frequently Asked Questions About Hormones

What are hormones and what do they do?
Hormones are chemical messengers secreted by endocrine glands and specialized cells, transported through the bloodstream, and detected by target tissues where they bind specific receptor proteins and produce physiological responses. They regulate metabolism, growth, reproduction, fluid and electrolyte balance, the immune system, mood, and the stress response — essentially coordinating all long-range communication between organs and systems. A hormone’s effect depends entirely on which receptor is present in the target tissue — the same hormone can produce different or even opposing effects in different organs based on receptor subtype and downstream signaling. Students working on biology or physiology assignments involving hormones can access specialist support through our biology assignment help service.
What is the difference between endocrine, paracrine, and autocrine signaling?
These terms describe the spatial range of a chemical signaling event. Endocrine signaling: the hormone is released into the bloodstream and acts on distant target cells — the classical definition of hormonal communication (insulin from the pancreas acting on skeletal muscle throughout the body). Paracrine signaling: the molecule acts locally on adjacent cells without systemic distribution — prostaglandins at an inflammatory site, or the local action of testosterone within the testis supporting spermatogenesis. Autocrine signaling: a cell secretes a molecule that acts on its own surface receptors — common in immune cell activation and a mechanism exploited by many cancer cells to drive their own proliferation. Most molecules classified as hormones operate in more than one mode depending on context.
What are the three main chemical classes of hormones?
Peptide/protein hormones (most hormones fall here — insulin, GH, TSH, ACTH, PTH, ADH, oxytocin): water-soluble, act via cell-surface receptors, effects begin within seconds to minutes through second-messenger cascades. Steroid hormones (cortisol, aldosterone, sex steroids, vitamin D): lipid-soluble, derived from cholesterol, diffuse through cell membranes and act via intracellular nuclear receptors to regulate gene transcription, effects develop over hours to days. Amine hormones (derived from tyrosine): catecholamines (adrenaline, noradrenaline) — water-soluble, act via cell-surface adrenoceptors, rapid effects; thyroid hormones (T3, T4) — lipophilic despite amino acid origin, act via nuclear receptors like steroids, slow onset and prolonged effects. Understanding these three classes explains the time course, mechanism, and pharmacology of each hormone class.
What is the hypothalamic-pituitary axis and why is it important?
The hypothalamic-pituitary axis is the hierarchy through which the brain controls peripheral endocrine gland function. The hypothalamus produces releasing hormones (CRH, TRH, GnRH, GHRH) that travel via the portal blood to the anterior pituitary, stimulating trophic hormone secretion (ACTH, TSH, FSH/LH, GH). These trophic hormones then stimulate their respective peripheral glands (adrenal cortex, thyroid, gonads). It is important because it allows the brain to integrate physiological, psychological, and environmental information and translate it into coordinated hormonal responses across the body. Understanding the axis is clinically essential because disruption at any level — hypothalamus, pituitary, or peripheral gland — produces characteristic biochemical patterns (the relationship between trophic and peripheral hormone levels) that distinguish primary from secondary endocrine disease and guide treatment.
How does insulin regulate blood glucose?
Rising blood glucose after a meal stimulates pancreatic beta cells to secrete insulin via ATP-mediated closure of K+ channels, membrane depolarization, and calcium-triggered exocytosis. Insulin lowers blood glucose by: (1) stimulating GLUT4 glucose transporter translocation to the surface of skeletal muscle and adipose cells, allowing glucose uptake; (2) promoting hepatic and muscle glycogen synthesis; (3) inhibiting hepatic gluconeogenesis and glycogenolysis; and (4) promoting triglyceride synthesis and inhibiting lipolysis. Insulin acts via the insulin receptor (a receptor tyrosine kinase) through the IRS/PI3K/Akt signaling cascade. In type 1 diabetes, beta cell destruction eliminates insulin production; in type 2, peripheral insulin resistance impairs the cellular response to insulin, initially compensated by beta cell hyperinsulinaemia but ultimately resulting in relative insulin deficiency as beta cells progressively fail.
What are the main hormones produced by the adrenal glands?
The adrenal glands have two functionally distinct parts. The adrenal cortex produces: cortisol (zona fasciculata, under ACTH control — regulates metabolism, anti-inflammatory effects, and the sustained stress response); aldosterone (zona glomerulosa, under angiotensin II and potassium control — promotes renal sodium retention and potassium excretion, regulating blood pressure and fluid balance); and adrenal androgens DHEA and androstenedione (zona reticularis — weak androgens that contribute to the androgen pool, particularly important in females). The adrenal medulla — modified sympathetic neural tissue — produces adrenaline (~80%) and noradrenaline (~20%) in response to sympathetic nerve activation, mediating the rapid fight-or-flight cardiovascular and metabolic response to acute stress.
What is negative feedback in the endocrine system?
Negative feedback is the mechanism by which the output of a hormonal axis suppresses its own upstream regulatory signals, keeping hormone concentrations stable around a set point. In the HPT axis: TRH → TSH → T3/T4; high T3/T4 suppresses both TRH and TSH secretion, reducing thyroid stimulation when hormone levels are adequate; low T3/T4 releases this suppression, allowing TRH and TSH to rise and drive more thyroid output. This self-correcting loop is why measuring TSH is diagnostically powerful — elevated TSH indicates the pituitary is detecting insufficient thyroid hormone (primary hypothyroidism); suppressed TSH indicates excess thyroid hormone (hyperthyroidism or exogenous thyroid hormone). Disruption of negative feedback — by hormone-producing tumours that are autonomous, or by exogenous hormone administration — is the basis of several important clinical scenarios.
What is the difference between hypothyroidism and hyperthyroidism?
Hypothyroidism is insufficient thyroid hormone production — most commonly from Hashimoto’s autoimmune thyroiditis. Clinical features reflect reduced metabolic rate: fatigue, weight gain, cold intolerance, constipation, bradycardia, dry skin, depression, cognitive slowing, and raised cholesterol. TSH is elevated (pituitary compensating for low T4); free T4 is low. Treatment is daily oral levothyroxine, dosed to normalize TSH. Hyperthyroidism is excess thyroid hormone — most commonly from Graves’ disease (TSH receptor stimulating antibodies). Clinical features reflect increased metabolic rate: weight loss, heat intolerance, sweating, palpitations, tachycardia, tremor, anxiety, and exophthalmos (in Graves’). TSH is suppressed; free T4 and T3 are elevated. Treatment is antithyroid drugs (carbimazole), radioiodine, or thyroid surgery. For nursing students writing case studies on thyroid disorders, our nursing assignment help service provides subject-specialist support.

Biology, Nursing, and Health Science Academic Writing Support

From endocrinology assignments and physiology essays to nursing case studies and biomedical dissertations — subject specialists across all health and life science disciplines at every academic level.

Explore All Services
Article Reviewed by

Simon

Experienced content lead, SEO specialist, and educator with a strong background in social sciences and economics.

Bio Profile

To top